A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension
Clinical trial NCT01878201 · COMPLETED
Trial details
- NCT number
- NCT01878201
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-02-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.